France approves antibody therapy for high-risk COVID cases

French health authorities have approved the use of an anti-body treatment made by AstraZeneca for high-risk people who show resistance to vaccines against coronavirus.

source https://medicalxpress.com/news/2021-12-france-antibody-therapy-high-risk-covid.html